IR-MED INC (IRME:OTCMKTS)
$0.007 0.0019 (37.2549%)
Analysed IR-MED INC (IRME:OTCMKTS) News Sources
IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment
03-11-2025
yahoo.com
IR-MED's Key Clinical and Media Milestones
27-10-2025
yahoo.com
IR-MED Investor Update Letter - Sept-2025
16-09-2025
yahoo.com
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones
23-06-2025
yahoo.com
IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
05-05-2025
yahoo.com
What is the current price of IR-MED INC (IRME:OTCMKTS)?
The current price of IR-MED INC (IRME:OTCMKTS) is $0.007.
IR-MED INC (IRME:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IR-MED INC (IRME:OTCMKTS) since the previous trading day is $0.0019.
IR-MED INC (IRME:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IR-MED INC (IRME:OTCMKTS) since the previous trading day is 37.2549%.
What is the most recent average sentiment score for IR-MED INC (IRME:OTCMKTS)?
The most recent average sentiment score for IR-MED INC (IRME:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for IR-MED INC (IRME:OTCMKTS)?
The most recent sentiment for IR-MED INC (IRME:OTCMKTS) is .
SEC-8K** Filing Available For IR-MED INC (IRME:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.